| Lenalidomide |
Biologic therapy (BRM, immunotherapy)
|
5q- MDS,
CLL,
MDS,
Multiple myeloma,
melanoma,
Lymphoma
|
Yes
|
| Intravenous Immune Globulin |
Biologic therapy (BRM, immunotherapy)
|
AIDS,
CLL,
Opportunistic infection
|
Yes
|
| Sulfadiazine |
Ancillary Agent,
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| Interferon Alfa-2a |
Biologic therapy (BRM, immunotherapy)
|
AIDS,
Opportunistic infection
|
Yes
|
| Interleukin-6 |
Biologic therapy (BRM, immunotherapy)
|
AIDS,
Opportunistic infection
|
Yes
|
| Sulfamethoxazole |
Ancillary Agent,
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| Recombinant Soluble Human CD4 |
Biologic therapy (BRM, immunotherapy)
|
AIDS,
Opportunistic infection
|
Yes
|
| Poly I: Poly C |
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| Somatrem |
Hormones and hormonal mechanisms
|
AIDS,
Opportunistic infection
|
Yes
|
| Acetylcysteine |
Ancillary Agent
|
AIDS,
Opportunistic infection
|
No
|
| Interleukin-1 beta |
Biologic therapy (BRM, immunotherapy)
|
AIDS,
Opportunistic infection
|
Yes
|
| Malathion |
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| Interferon Alfa-n1 |
Biologic therapy (BRM, immunotherapy)
|
AIDS,
Opportunistic infection
|
Yes
|
| Erythropoietin |
Ancillary Agent
|
AIDS,
Opportunistic infection
|
No
|
| Interferon natural |
Biologic therapy (BRM, immunotherapy)
|
AIDS,
Opportunistic infection
|
Yes
|
| Lomotil |
Ancillary Agent,
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| Metronidazole |
Ancillary Agent,
AIDS drug,
Other therapy
|
AIDS,
Opportunistic infection
|
See Remarks
|
| Voriconazole |
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| Sparfloxacin |
Ancillary Agent,
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| Spiramycin |
Ancillary Agent,
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| Inolimomab |
AIDS drug
|
AIDS,
Opportunistic infection
|
Yes
|
| Interferon gamma-1b |
Biologic therapy (BRM, immunotherapy)
|
AIDS,
Opportunistic infection
|
Yes
|
| Mexiletine Hydrochloride |
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| Trimethoprim |
Ancillary Agent,
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| Interleukin-10 |
Biologic therapy (BRM, immunotherapy)
|
AIDS,
Opportunistic infection
|
Yes
|
| Interferon beta-1b |
Ancillary Agent
|
AIDS,
Opportunistic infection
|
No
|
| Miconazole |
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| Mitoguazone |
Chemotherapy
|
AIDS,
Opportunistic infection
|
Yes
|
| Nitrofurazone |
Ancillary Agent
|
AIDS,
Opportunistic infection
|
No
|
| Lentinan |
Biologic therapy (BRM, immunotherapy),
AIDS drug
|
AIDS,
Opportunistic infection
|
Yes
|
| Mupirocin |
Ancillary Agent
|
AIDS,
Opportunistic infection
|
No
|
| Letrazuril |
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| Interferon alfacon-1 |
Biologic therapy (BRM, immunotherapy)
|
AIDS,
Opportunistic infection
|
Yes
|
| Milodistim |
Ancillary Agent
|
AIDS,
Opportunistic infection
|
No
|
| Tioconazole |
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
| CSF-2 |
Ancillary Agent
|
AIDS,
Opportunistic infection
|
No
|
| Interleukin-2 |
Biologic therapy (BRM, immunotherapy)
|
AIDS,
breast,
head & neck cancer,
leukemia,
lymphoma,
Opportunistic infection
|
Yes
|
| SGN-30 |
Chemotherapy
|
ALCL,
Lymphoma
|
Yes
|
| SCH-900776 |
Chemotherapy
|
ALL,
AML,
CML,
Hodgkin,
NHL
|
Yes
|
| Clofarabine |
Chemotherapy
|
ALL,
AML,
CML,
Leukemia,
lymphoma,
myeloproliferative disease,
other cancer
|
Yes
|
| Cytarabine |
Chemotherapy
|
ALL,
AML,
CML,
head and neck,
Hodgkin's disease,
leukemia,
Meningeal leukemia,
NHL
|
Yes
|
| Treosulfan |
Chemotherapy
|
ALL,
AML,
MDS
|
No
|
| Onco-TCS |
Chemotherapy
|
ALL,
leukemia,
Lung cancer,
lymphoma
|
Yes
|
| SKI-606 |
Chemotherapy
|
AML
|
Yes
|
| Cyclopentenyl-cytosine |
Chemotherapy
|
AML
|
Yes
|
| XIAP antisense |
Chemotherapy
|
AML
|
Yes
|
| Valproic acid |
Chemotherapy
|
AML,
CLL,
lymphocytic lymphoma
|
See Remarks
|
| SB-1518 |
Chemotherapy
|
AML,
CML,
MDS
|
Yes
|
| Lovastatin |
Chemotherapy
|
AML,
Hepatoma,
stomach
|
Yes
|
| LBH-589 |
Chemotherapy
|
AML,
Hodgkin lymphoma,
MDS,
multiple myeloma
|
Yes
|
| Cloretazine |
Chemotherapy
|
AML,
Leukemia,
other cancers,
SCLC
|
Yes
|
| MGCD0103 |
Chemotherapy
|
AML,
MDS
|
Yes
|
| Lintuzumab |
Chemotherapy
|
AML,
MDS
|
Yes
|
| LY-2181308 |
Chemotherapy
|
AML,
Prostate
|
Yes
|
| Lestaurinib |
Chemotherapy
|
AML,
leukemia,
other cancer,
Pancreatic,
prostate
|
Yes
|
| Volasertib |
Chemotherapy
|
AML trials,
Ovarian trials,
Solid tumors trials
|
Yes
|
| Tretinoin |
Differentiation inducing agent
|
Acute Promyelocytic leukemia (APL),
AIDS,
head & neck cancer,
Opportunistic infection
|
See Remarks
|
| Asparaginase |
Chemotherapy
|
Acute lymphoblastic leukemia (ALL)
|
Yes
|
| Erwinaze |
Chemotherapy
|
Acute lymphoblastic leukemia (ALL)
|
Yes
|
| Omacetaxine |
Chemotherapy
|
Acute lymphoblastic leukemia (ALL),
Acute myelogenous leukemia (AML),
Chronic myelogenous leukemia (CML),
Myelodysplastic syndrome (MDS)
|
Yes
|
| Idarubicin |
Chemotherapy
|
Acute lymphoblastic leukemia (ALL),
Acute myelogenous leukemia (AML),
Chronic myelogenous leukemia in blast crises,
Myelodysplastic syndromes (MDS)
|
Yes
|
| Methotrexate |
Chemotherapy
|
Acute lymphoblastic leukemia (ALL),
Bladder cancer,
Breast,
Gestational trophoblastic cancer,
head & neck cancer,
lymphoma,
Meningeal leukemia,
Non-Hodgkin lymphoma,
Osteogenic sarcoma,
Primary CNS lymphoma
|
Yes
|
| Roscovitine |
Chemotherapy
|
Acute myelogenous leukemia (AML),
B-cell lymphomas,
Non small cell lung cancer (NSCLC)
|
Yes
|
| Mitoxantrone |
Chemotherapy
|
Acute myelogenous leukemia (AML),
Breast,
Non-Hodgkin lymphoma,
Prostate- advanced hormone-refractory
|
Yes
|
| Vanflyta |
Chemotherapy
|
Acute myeloid leukemia,
AML
|
Yes
|
| KW-0761 |
Chemotherapy
|
Adult T-cell leukemia/lymphoma,
peripheral T-cell leukemia/lymphoma
|
Yes
|
| XL-147 |
Chemotherapy
|
Advanced Endometrium,
lymphoma,
Mets breast,
NSCLC,
ovarian
|
Yes
|
| Tetrahydrouridine |
Chemotherapy
|
Advanced solid tumors
|
Yes
|
| Carboplatin |
Chemotherapy
|
All cancers
|
Yes
|
| Brentuximab vedotin |
Biologic therapy (BRM, immunotherapy)
|
Anaplastic large cell lymphoma (ALCL),
Hodgkin Lymphoma
|
Yes
|
| Norethandrolone |
Hormones and hormonal mechanisms
|
Aplastic anemia
|
Yes
|
| Ketoconazole |
Hormones and hormonal mechanisms
|
As a testosterone blocker for advanced prostate cancer,
as an antifungal for AIDS,
opportunistic infections
|
Yes
|
| Flavopiridol |
Chemotherapy
|
B-cell CLL,
Colorectal,
lung,
other cancer,
prolymphocytic leukemia arising from CLL,
small lymphocytic lymphoma
|
Yes
|
| MEDI-551 |
Biologic therapy (BRM, immunotherapy)
|
B-cell malignancies
|
Yes
|
| Ibrutinib |
Chemotherapy
|
B-cell malignancies,
CLL,
Mantle cell lymphoma,
Multiple myeloma,
NHL,
Waldentrom macroglobulinemia (WM),
diffuese B-cell lymphoma,
SLL
|
Yes
|
| Vismodegib |
Chemotherapy
|
Basal cell carcinoma, skin
|
Yes
|
| Propranolol |
Other therapy
|
Benign hemangioma
|
No
|
| Ziihera |
Biologic therapy (BRM, immunotherapy)
|
Bile ducts, Gall bladder
|
Yes
|
| Ethylchlorformate |
Biologic therapy (BRM, immunotherapy)
|
Bladder
|
Yes
|
| Padcev |
Biologic therapy (BRM, immunotherapy)
|
Bladder
|
Yes
|
| Erdafitinib |
Chemotherapy
|
Bladder
|
Yes
|
| Enfortumab vedotin |
Biologic therapy (BRM, immunotherapy)
|
Bladder
|
Yes
|
| Anktiva |
Biologic therapy (BRM, immunotherapy)
|
Bladder
|
Yes
|
| Jelmyto |
Chemotherapy
|
Bladder
|
Yes
|
| Bropirimine |
Biologic therapy (BRM, immunotherapy)
|
Bladder
|
Yes
|
| Gemcitabine |
Chemotherapy
|
Bladder,
Breast,
non-small cell lung,
ovarian,
pancreatic cancer,
Soft Tissue Sarcoma
|
Yes
|
| Ifosfamide |
Chemotherapy
|
Bladder,
Cervical cancer,
Ewing sarcoma,
Head and Neck,
Hodgkin lymphoma,
Non-Hodgkin lymphoma,
Non-small cell and small cell lung cancer,
Soft tissue sarcoma, osteogenic sarcoma,
Testicular cancer
|
Yes
|
| Durvalumab |
Biologic therapy (BRM, immunotherapy)
|
Bladder,
Lung,
Biliary tract,
Endometrium,
Liver
|
Yes
|
| Atezolizumab |
Biologic therapy (BRM, immunotherapy)
|
Bladder,
Lung,
Liver,
Breast,
Soft tissue
|
Yes
|
| Diaziquone |
Chemotherapy
|
Bladder,
brain,
skin cancer
|
Yes
|
| Eflornithine |
Chemotherapy
|
Bladder,
brain (glioblastoma),
childhood leukemia,
CML,
skin cancer
|
Yes
|
| TOCOSOL |
Chemotherapy
|
Bladder,
breast,
colorectal,
lung,
ovarian cancers
|
Yes
|
| Cancer Vaccine |
Biologic therapy (BRM, immunotherapy)
|
Bladder,
breast,
kidney,
ovarian,
skin cancer
|
Yes
|
| Doxorubicin |
Chemotherapy
|
Bladder,
breast,
liver,
multiple myeloma,
ovarian,
pancreatic,
prostate cancer
|
Yes
|
| Vinflunine |
Chemotherapy
|
Bladder,
breast,
lung,
other
|
Yes
|
| Celebrex |
Ancillary Agent
|
Bladder,
breast cancer
|
No
|
| Cisplatin |
Chemotherapy
|
Bladder,
ovarian,
testicular cancer
|
Yes
|
| Apaziquone |
Ancillary Agent,
Chemotherapy
|
Bladder cancer
|
See Remarks
|
| Valrubicin |
Chemotherapy
|
Bladder cancer
|
Yes
|
| Levulan |
Ancillary Agent
|
Bladder cancer
|
No
|
Home
An official website of the United States government
